Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE:002773)
China
· Delayed Price · Currency is CNY 25.78
-0.02 (-0.08%)
May 14, 2025, 12:44 PM CST
SHE:002773 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 1,218 | 1,191 | 1,045 | 896.67 | 421.08 | -269.85 | Upgrade
|
| Depreciation & Amortization | 230.41 | 230.41 | 222.6 | 158.27 | 149.38 | 118.5 | Upgrade
|
| Other Amortization | 3.98 | 3.98 | 3.72 | 4.57 | 2.44 | 3 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.01 | -0.01 | -0.01 | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 2.19 | 2.19 | 1.35 | 0.68 | 215.06 | 1.76 | Upgrade
|
| Loss (Gain) From Sale of Investments | -47.28 | -47.28 | -45.03 | -38.06 | -26.43 | -34.09 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.39 | 0.39 | 0.24 | -0.4 | -2.64 | -1.16 | Upgrade
|
| Other Operating Activities | -11.51 | -12.16 | -11.9 | -27.74 | 0.97 | -1.83 | Upgrade
|
| Change in Accounts Receivable | -45.75 | -45.75 | -5.82 | 16.12 | 151.98 | 96.35 | Upgrade
|
| Change in Inventory | 13.79 | 13.79 | -65.01 | -38.46 | -57.03 | 23.02 | Upgrade
|
| Change in Accounts Payable | -30.38 | -30.38 | -61.36 | -116.71 | -249.47 | -34.45 | Upgrade
|
| Change in Other Net Operating Assets | 1.75 | 1.75 | 3.82 | 7.79 | 4.71 | 733.42 | Upgrade
|
| Operating Cash Flow | 1,439 | 1,412 | 1,218 | 925.15 | 494.11 | 273.32 | Upgrade
|
| Operating Cash Flow Growth | 0.16% | 15.88% | 31.70% | 87.23% | 80.78% | -66.35% | Upgrade
|
| Capital Expenditures | -154.61 | -159.39 | -138.87 | -355.21 | -569.42 | -621.84 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.55 | 0.55 | 0.2 | 0.06 | 0.08 | 0.04 | Upgrade
|
| Investment in Securities | -689.21 | - | 100 | 100 | -251.85 | -10 | Upgrade
|
| Other Investing Activities | 47.07 | 46.79 | 45.29 | 39.6 | 18.06 | 47.84 | Upgrade
|
| Investing Cash Flow | -796.2 | -112.06 | 6.62 | -215.55 | -803.14 | -583.96 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 7.71 | Upgrade
|
| Total Debt Issued | - | - | - | - | - | 7.71 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -7.71 | Upgrade
|
| Long-Term Debt Repaid | - | -1.49 | -1.99 | -2.6 | -2.13 | - | Upgrade
|
| Total Debt Repaid | -1.49 | -1.49 | -1.99 | -2.6 | -2.13 | -7.71 | Upgrade
|
| Net Debt Issued (Repaid) | -1.49 | -1.49 | -1.99 | -2.6 | -2.13 | - | Upgrade
|
| Issuance of Common Stock | 6.75 | 6.75 | - | - | - | 1,606 | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | - | -0.35 | Upgrade
|
| Common Dividends Paid | -349.4 | -349.4 | -137.92 | -91.95 | -91.95 | -244.6 | Upgrade
|
| Other Financing Activities | -1.1 | - | 9.41 | 20.7 | 15.24 | -4.37 | Upgrade
|
| Financing Cash Flow | -345.24 | -344.14 | -130.5 | -73.85 | -78.84 | 1,357 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.36 | -0.25 | -0.21 | 0.99 | -0.87 | -2.6 | Upgrade
|
| Net Cash Flow | 297.21 | 955.43 | 1,094 | 636.74 | -388.73 | 1,044 | Upgrade
|
| Free Cash Flow | 1,284 | 1,252 | 1,080 | 569.95 | -75.3 | -348.53 | Upgrade
|
| Free Cash Flow Growth | -1.23% | 16.02% | 89.41% | - | - | - | Upgrade
|
| Free Cash Flow Margin | 28.18% | 28.13% | 27.28% | 16.82% | -2.09% | -10.58% | Upgrade
|
| Free Cash Flow Per Share | 1.39 | 1.37 | 1.18 | 0.62 | -0.08 | -0.40 | Upgrade
|
| Cash Income Tax Paid | 407.71 | 400.54 | 391.52 | 343.76 | 450.78 | 463.03 | Upgrade
|
| Levered Free Cash Flow | 865.75 | 850.51 | 681.33 | 398.96 | -399.12 | -565.33 | Upgrade
|
| Unlevered Free Cash Flow | 865.75 | 850.51 | 681.33 | 398.96 | -399.12 | -565.02 | Upgrade
|
| Change in Net Working Capital | -1.1 | -3.52 | 97.87 | -43.24 | 240.45 | -340.03 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.